Quinazoline derivatives
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Nov 13, 2007
Grant Date -
Jun 17, 2004
app pub date -
Feb 21, 2002
filing date -
Feb 21, 2001
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
A compound of the formula (I) ##STR00001## or a pharmaceutically acceptable salt thereof, a hydrate thereof, a solvate thereof, an optically active compound thereof, a racemate thereof or a diastereomer mixture thereof has a superior tyrosine-specific protein kinase inhibitory activity and is useful as a pharmaceutical agent, particularly as an agent for the prophylaxis or treatment of various cancers, psoriasis or diseases caused by arteriosclerosis, and the like.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully